The Lancet in conversation with
by The Lancet Group
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇯🇵JP · Medicine#1241K to 10K
- 🇰🇷KR · Medicine#1461K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1K to 10K🎙 Weekly cadence·39 episodes·Last published 1w ago - Monthly Reach
Unique listeners across all episodes (30 days)
2K to 20K🇯🇵50%🇰🇷50% - Active Followers
Loyal subscribers who consistently listen
600 to 6K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 14 epsHosts
Recent guests
Recent episodes
How should we manage cardiovascular conditions in pregnancy?
Aug 27, 2026
32m 22s
What’s the story with mRNA vaccines?
Jul 31, 2026
23m 35s
What are cardiometabolic long-term conditions?
Jul 10, 2026
19m 16s
Tania Nikolcheva, Gavin Giovannoni and Tharick Pascoal on the Special issue in Neurology
May 31, 2026
32m 34s
Paul Spiegel: rethinking the humanitarian response to conflict and forced displacement
May 19, 2026
31m 51s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 8/27/26 |  How should we manage cardiovascular conditions in pregnancy? | What cardiovascular issues can women experience in pregnancy, and why? Lancet editors Niall Boyce and Chloe Wilson talk with Professor Garima Sharma, one of the authors of a new Series of papers aiming to bring the cardiovascular health of pregnant women into the mainstream of primary and secondary care. Click here to read the full series: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01235-3/fulltext https://www.thelancet.com/journals/lanogw/article/PIIS3050-5038(26)00190-1/fulltext https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)01234-1/fulltext | 32m 22s | ||||||
| 7/31/26 | What’s the story with mRNA vaccines? | What are mRNA vaccine, how do they work, and how might they be used for in the future? And why is there a gap between the evidence and some people’s perception of their safety and efficacy? Niall Boyce from The Lancet talks to Anna Blakney, biomedical engineer and one of the authors of new Review paper "Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective". Click here to read the full article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00512-X/abstract | 23m 35s | ||||||
| 7/10/26 | cardiometabolic conditionshealth services+3 | Professor Kamlesh Khunti | University of LeicesterThe Lancet | — | cardiometaboliclong-term conditions+3 | — | 19m 16s | ||
| 5/31/26 | neurologyParkinson's disease+4 | Tania NikolchevaGavin Giovannoni+1 | The LancetPADOVA+4 | — | neurologyPADOVA trial+7 | — | 32m 34s | ||
| 5/19/26 | humanitarian responseconflict+4 | Paul Spiegel | Lancet CommissionThe Lancet | — | humanitarian responseconflict+3 | — | 31m 51s | ||
| 5/2/26 | alcohol use disordersemaglutide+3 | Kalypso Karastergiou | The LanceteBioMedicine | — | semaglutidealcohol use disorder+3 | — | 31m 49s | ||
| 2/3/26 | cancerpersonalized care+3 | Louise ChappellNa’ama Carlin | The Lancet Group | — | cancer storiespersonalized cancer care+3 | — | 30m 39s | ||
| 12/19/25 | global oncologyequity in healthcare+4 | Dr Susannah Stanway | Royal MarsdenInstitute of Cancer Research | — | canceroncology+5 | — | 24m 04s | ||
| 12/9/25 | ultra-processed foodshuman health+3 | Carlos MonteiroCamila Corvalán+1 | The Lancetglobal ultra-processed food industry+1 | — | ultra-processed foodshealth+5 | — | 1h 01m 17s | ||
| 12/7/25 | follicular lymphomaepcoritamab+3 | Franck Morschhauser | epcoritamablenalidomide+3 | — | follicular lymphomaepcoritamab+4 | — | 13m 03s | ||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 10/19/25 | cancer treatmentclinical trials+3 | Shun Lu | ivonescimabThe Lancet+1 | advanced squamous non-small-cell lung cancer | HARMONi-6ivonescimab+3 | — | 20m 43s | ||
| 10/17/25 | immunotherapybladder cancer+4 | Neal Shore | durvalumabThe Lancet+1 | non-muscle-invasive bladder cancer | POTOMAC studyimmunotherapy+5 | — | 22m 09s | ||
| 7/28/25 | liver cancerhepatocellular carcinoma+4 | Stephen Chan | The LancetLancet Commission+1 | — | liver cancerhepatocellular carcinoma+5 | — | 20m 41s | ||
| 7/24/25 | biomarker risk stratificationBarrett's oesophagus+3 | Rebecca Fitzgerald | Professor Rebecca Fitzgerald's teamBarrett's oesophagus | — | biomarkerrisk stratification+5 | — | 27m 15s | ||
| 6/11/25 | oncologyASCO conference+3 | Vania WisdomKatherine Gourd | The LancetThe Lancet Oncology | — | ASCO 2025oncology+3 | — | 14m 44s | ||
| 5/31/25 | CAR T-cell therapysolid tumours+3 | Changsong Qi | The LancetClaudin-18 isoform 2-specific CAR T-cell therapy | advanced gastric or gastro-oesophageal junction cancer | CAR T-cell therapysolid tumours+3 | — | 14m 45s | ||
| 5/30/25 | Previewing ASCO 2025 | Vania Wisdom, Senior Executive Editor at The Lancet and the journal's Oncology Ambassador, joins Gavin Cleaver to discuss what's being published at this year's American Society of Clinical Oncology (ASCO) meeting, what she's excited to see at the conference, and why ASCO is so important to the field. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/c... | 4m 54s | ||||||
| 3/14/25 | Francis Couturaud on treatment of venous thromboembolism | Francis Couturaud joins Chloe Wilson of The Lancet to discuss the RENOVE trial, which looks at assessing the efficacy and safety of reduced-dose versus full-dose direct oral anticoagulants in patients in whom extended anticoagulation has been indicated. Read the full paper: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02842-3/fulltext?dgcid=buzzsprout_icw_podcast_generic_lancet Continue this conversation on social! Follow us today at... https://thelancet.bsky.socia... | 28m 30s | ||||||
| 1/27/25 | Shawn St Peter on appendicectomy versus antibiotics for acute uncomplicated appendicitis in children | This week, we discuss treatment approaches for uncomplicated appendicitis in children following the publication of a trial in our January 18th issue. Lead author Shawn St Peter, general paediatric surgeon and surgeon-in-chief at Children’s Mercy Hospital, Kansas City, spoke with Callam Davidson about the motivation behind the study, key findings, and what the results mean for clinical practice. Read the full article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02420-6/... | 16m 01s | ||||||
| 1/9/25 | Michael Heneka on passive anti-amyloid β immunotherapy in Alzheimer’s disease | Michael Heneka joins Chloe Wilson and Bea Gomez Perez-Nievas of The Lancet to discuss a therapeutics paper discussing the opportunities and challenges of passive anti-amyloid β immunotherapy in Alzheimer's disease. Read the full article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01883-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lancet Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup ht... | 21m 35s | ||||||
| 10/31/24 | Nusrat Husain, Farah Lunat, and Fehmida Motala on postnatal depression in British south Asian women (the ROSHNI-2 trial) | ROSHNI-2 was a multicentre, randomised controlled trial that investigated the efficacy of a culturally adapted, cognitive behavioural therapy-based intervention for postnatal depression in British south Asian women. Joining us to share their expertise and perspectives are chief investigator Professor Nusrat Husain, trial manager Farah Lunat, and service user representative Fehmida Motala. Read the full article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01612-X/fullte... | 48m 44s | ||||||
| 10/10/24 | Rasha Al-Lamee and Shayna Chotai on ESC 2024 highlights | Rasha Al-Lamee and Shayna Chotai join Chloe Wilson of The Lancet to discuss ESC Congress 2024 highlights. The papers featured on this podcast are: 1) https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01733-1/fulltext 2) https://www.nejm.org/doi/abs/10.1056/NEJMoa2409134 3) https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01454-5/abstract 4) https://www.nejm.org/doi/abs/10.1056/NEJMoa2314328 5) https://www.escardio.org/Guidelines/Clinical-Practice-Guideline... | 40m 18s | ||||||
| 9/5/24 | Dr Oriol Mitjà and Dr Hypolite Muhindo Mavoko on mpox | On August 14th, the World Health Organisation declared a public health emergency of international concern in relation to mpox. This was motivated, in part, by the emergence of a concerning new strain of mpox, clade 1b, which has spread rapidly across Central Africa. Joining me this week to discuss important clinical aspects of the current mpox outbreak are Dr Oriol Mitja, Associate Professor at the Germans Trias Research Institute in Barcelona, and Dr Hypolite Muhindo Mavoko from the Departme... | 26m 26s | ||||||
| 8/8/24 | Natasha Pocovi on the prevention of low back pain recurrence | Natasha Pocovi joins Chloe Wilson of The Lancet to discuss a trial investigating a walking and education intervention for the prevention of low back pain recurrence in Australia (WalkBack). Read the full article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00755-4?dgcid=buzzsprout_tlv_podcast_generic_lancet Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedica... | 23m 50s | ||||||
| 5/2/24 | Prasad Kulkarni on a vaccine against typhoid and paratyphoid | Prasad Kulkarni joins Callam Davidson of The Lancet to discuss the safety and immunogenicity of a bivalent conjugate vaccine against typhoid and paratyphoid, following the publication of a phase 1 trial. Read the full article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00249-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lancet Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://faceb... | 18m 06s | ||||||
Showing 25 of 45
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for The Lancet in conversation with
Peaked at #124 in Japan, currently #124 in Japan.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| Japan | — | #124 | #124 | — |
| South Korea | — | #146 | #146 | — |
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.